이은신 교수의 진료시간표

이은신 교수의 상세정보

•  ~  2005 .02  :  경북 대학교 의과대학 졸업
•  ~  2020 .08  :  서울대학교 의과대학 의학과 석사
• 2020 .09  ~   :  서울대학교 의과대학 박사과정 중

• 2013  ~  2015  :  서울대학교병원 유방센터 외과 임상 강사
• 2016  ~  2019  :  서울대학교병원 유방센터 외과 진료조교수
• 2019  ~  2020  :  서울대학교병원 강남센터 외과 외래교수
• 2016 .12  ~  2017 .01  :  Dana Farber/Brigham and Women’s Cancer Center, Boston, MA. 유방 종양 외과 단기연수

• 2017  :  Young investigator award, Global Breast Cancer Conference

•  ~   :  대한외과학회 정회원
•  ~   :  한국유방암학회 정회원
•  ~   :  한국유방암학회 유방암성형술 연구회 간사

• 2014 .03  ~   :  Presentation at <SISSO 2014> Characteristics of recurrence after completing adjuvant tamoxifen therapy for 5 years
• 2017 .03  ~   :  Presentation at <SISSO 2017> An alteration of hormonal receptor status throughout tumor progression related to prognosis in breast cancer patients. -> Best Poster Presentation award
• 2018 .03  ~   :  Presentation at <SISSO 2018> Clinical application of multigene panel testing and association between germline mutations in predisposition genes and clinicopathological factors in patients with high risk for hereditary breast cancer. -> Best Poster Presentation award
• 2017 .05  ~   :  Presentation at <GBCC 2017> Clinical application of multigene panel testing and association between germline mutations in predisposition genes and clinicopathological factors in patients with high risk for hereditary breast cancer
• 2018 .05  ~   :  Presentation at <GBCC 2018> ASSOCIATIONS BETWEEN GERMLINE MUTATIONS IN PREDISPOSITION GENES AND CLINICOPATHOLOGICAL FACTORS INCLUDING BREAST CANCER SUBTYPES AND AGE OF PATIENTS WITH HIGH RISK FOR HEREDITARY BREAST CANCER

• 2013 .12  ~   :  Presentation at <2013 San Antonio Breast Cancer Symposium>, Texas, Clinical benefits of using nomogram for predicting positive resection margins in breast conserving surgery
• 2014 .12  ~   :  Presentation at <2014 San Antonio Breast Cancer Symposium>, Texas, Discovery of novel amplified genes in primary breast cancer with copy number and gene expression analysis of whole exome and transcriptome sequencing data
• 2014 .12  ~   :  Presentation at <2014 San Antonio Breast Cancer Symposium>, Texas, Characteristics of recurrence after completing adjuvant tamoxifen therapy for 5 years
• 2016 .12  ~   :  Presentation at <2016 San Antonio Breast Cancer Symposium>, Texas, An alteration of hormonal receptor status throughout tumor progression related to prognosis in breast cancer patients
• 2017 .09  ~   :  Presentation at <2017 European Breast Cancer Summit>, Italy, An alteration of hormonal receptor status throughout tumor progression related to prognosis in breast cancer patients
• 2017 .12  ~   :  Presentation at <2017 San Antonio Breast Cancer Symposium>, Texas, Clinical application of multigene panel testing and association between germline mutations in predisposition genes and clinicopathological factors in patients with high risk for hereditary breast cancer

• [SCI] (Identifying the potential long-term survivors among breast cancer patients with distant metastasis)
• [SCI] (Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer)
• [SCI] (Clinical benefit of nomogram for predicting positive resection margins in breast conserving surgery)
• [SCI] (Effects of tamoxifen and aromatase inhibitors on the risk of acute coronary syndrome in elderly breast cancer patients: An analysis of nationwide dat)
• [SCI] (Development of a Nomogram to Predict the Recurrence Score of 21-Gene Prediction Assay in Hormone Receptor-Positive Early Breast Cancer)
• [SCI] (Tumor Suppressor miRNA-204-5p Regulates Growth, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer)
• [SCI] (Endocrine Treatment-Related Symptoms and Patient Outcomes in Breast Cancer: A Meta-Analysis)
• [SCI] (Transfer-RNA-mediated enhancement of ribosomal proteins S6 kinases signalling for cell proliferation)
• [SCI] (Can We Skip Intraoperative Evaluation of Sentinel Lymph Nodes? - Nomogram Predicting Involvement of Three or More Axillary Lymph Nodes Before Breast Cancer Surgery)
• [SCI] (The treatment outcomes and the use of adjuvant therapies in breast cancer patients with severe co-morbidities)
• [SCI] (Delay of Treatment Initiation Does Not Adversely Affect Survival Outcome in Breast Cancer)
• [SCI] (In Vivo Tumor Growth Rate Measured by US in Preoperative Period and Long Term Disease Outcome in Breast Cancer Patients)
• [SCI] (Risk Factors Associated with Distant Metastasis and Survival Outcomes in Breast Cancer Patients with Locoregional Recurrence)
• [SCI] (Effect of cosmetic outcome on quality of life after breast cancer surgery)
• [SCI] (The Value of Ki67 in Very Young Women with Hormone Receptor-Positive Breast Cancer: Retrospective Analysis of 9,321 Korean Women)
• [SCI] (Immediate Breast Reconstruction vs. Mastectomy Alone in Locally Advanced Breast Cancer; Local Recurrence and Distant Recurrence)
• [SCI] (Actual Conversion Rate from Total Mastectomy to Breast Conservation after Neoadjuvant Chemotherapy for Stages II&#8211;III Breast Cancer Patients)

• Personalized Treatment of Breast Cancer (Japan, Editor : Masakazu Toi, Eric Winer, John Benson, Suzanne Klimberg)
• 유방 초음파 진단한 2판

최종수정일 : 2020.11.30